Relapse in Kala Azar: Failure of Sodium Stibogluconate to Clear Parasites from Organs Other than the Liver
Relapse in Kala-azar is a common problem, occurring in 5–30% of patients (Chulay et al, 1983, Sanyal and Arora, 1979). Although this could be attributed to re-infection, there is a strong possibility that it may at least partly be due to treatment failure. Two recent studies suggest that removal of parasites from certain tissue sites may be difficult.
KeywordsVisceral Leishmaniasis Parasite Burden Muramyl Dipeptide Parasite Number Sodium Stibogluconate
Unable to display preview. Download preview PDF.
- Adinolfi, L.E., Bonventre, P.F., Vander Pas, M. and Eppstein, D.A. (1985) Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect. and Immun., 48:409.Google Scholar
- Anabwani, G.M., Ngira, J.A., Dimiti, G. and Bryceson, A.D.M. (1983) Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet, 29 July, 1983, 211.Google Scholar
- Carter, K.C., Baillie, A.J., Alexander, J. and Dolan, T.F. (1987) submitted J. Pharm.Pharmacol. The therapeutic effect of sodium stibogluconate in BALB/c mice infected with L. donovani is organ dependent.Google Scholar
- Napier, L.E. (1946) in “The Principles and Practice of Tropical Medicine”, p.134, Macmillan, New York.Google Scholar
- Sanyal, R.K. and Arora, R.R. (1979) Assessment of drug therapy of Kala-azar in current epidemic in Bihar.J.Commun.Dis., 11:198.Google Scholar